Jon Fortt sits down with The New York Times' Farhad Manjoo and John Stanton, co-founder of the Save Journalism Project, to discuss Mark Zuckerberg's congressional testimony on Facebook's libra project.
CEO Mark Zuckerberg is back in Washington this week arguing for libra, the digital currency his company created.
This, after he last week made the case in front of an audience at Georgetown University that Facebook's future, its past and its reason for being are all tied up in free speech.Jon Fortt sits down with The New York Times' Farhad Manjoo and John Stanton, co-founder of the Save Journalism Project, to discuss Zuckerberg's congressional testimony on Facebook's libra project.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Facebook's Mark Zuckerberg faces bipartisan hostility at congressional hearingFacebook CEO Mark Zuckerberg faces bipartisan, hostile questioning at a congressional hearing on his company's plans to launch its own cryptocurrency.
Read more »
Facebook deleted Russian accounts just days before Mark Zuckerberg will testify to CongressAlexandria Ocasio-Cortez is on the committee that will question Zuckerberg on Capitol Hill tomorrow.
Read more »
Zuckerberg to tell Congress Facebook is 'not the ideal messenger' for Libra currencyFacebook Chief Executive Mark Zuckerberg plans to acknowledge before Congress th...
Read more »
Zuckerberg faces grilling on Facebook's ambitious digital currency plansFacebook Inc chief executive Mark Zuckerberg will be grilled by lawmakers over t...
Read more »
What Mark Zuckerberg’s Cryptocurrency Testimony Shows About Facebook’s Libra StrategyAn analysis of Facebook CEO Mark Zuckerberg's planned testimony before congress on the libra cryptocurrency.
Read more »
Facebook's Zuckerberg grilled in U.S. Congress on digital currency, privacy, electionsMark Zuckerberg told a congressional committee that Facebook would not back any move by Libra to launch the cryptocurrency until it satisfies U.S. regulatory concerns
Read more »